Table 4.
Comparison of long-term consequences of asymptomatic and symptomatic SARS-CoV-2 infection.
| Consequences | Data Source | Asymptomatic Infection n/N |
Symptomatic Infection n/N |
OR | 95%CI | p-Value | I2 (%) | p-Heterogeneity |
|---|---|---|---|---|---|---|---|---|
| At least one symptom | 1, 2, 4, 5 | 76/543 | 576/1041 | 0.20 | 0.09–0.45 | <0.05 | 79.40 | <0.05 |
| Fatigue | 1, 2, 4, 5 | 19/543 | 212/1041 | 0.19 | 0.08–0.49 | <0.05 | 61.30 | <0.05 |
| Headache | 2, 4, 5 | 4/144 | 59/811 | 0.34 | 0.12–1.06 | >0.05 | 0.00 | >0.05 |
| Cough | 2, 4, 5 | 3/144 | 28/811 | 0.64 | 0.17–2.43 | >0.05 | 17.10 | >0.05 |
| Hair loss | 4, 5 | 1/99 | 44/786 | 0.28 | 0.05–1.45 | >0.05 | 0.00 | >0.05 |
| Chest pain | 4, 5 | 0/99 | 22/786 | 0.35 | 0.05–2.66 | >0.05 | 0.00 | >0.05 |
| Cutaneous lesions | 1, 4, 5 | 4/498 | 36/1016 | 0.26 | 0.09–0.72 | <0.05 | 0.00 | >0.05 |
| Neurological symptoms | 1, 5 | 10/454 | 90/771 | 0.15 | 0.07–0.30 | <0.05 | 0.00 | >0.05 |
| Dyspnoea | 2, 4, 5 | 5/144 | 89/811 | 0.25 | 0.10–0.65 | <0.05 | 0.00 | >0.05 |
| Muscle or joint pains | 1, 4 | 12/443 | 102/475 | 0.20 | 0.10–0.38 | <0.05 | 0.00 | >0.05 |
| Loss of taste/smell | 1, 2, 5 | 4/499 | 86/796 | 0.10 | 0.02–0.58 | <0.05 | 53.50 | >0.05 |
| Gastrointestinal symptoms | 1, 5 | 7/454 | 21/771 | 0.34 | 0.14–0.83 | <0.05 | 0.00 | >0.05 |
| Ocular symptoms | 4, 5 | 2/99 | 21/786 | 0.72 | 0.19–2.75 | >0.05 | 0.00 | >0.05 |
| Psychiatric disorders | 1, 5 | 11/454 | 49/771 | 0.28 | 0.14–0.59 | <0.05 | 0.00 | >0.05 |
| Palpitations and cardiac disorders | 1, 4 | 2/443 | 27/475 | 0.18 | 0.04–0.81 | <0.05 | 0.00 | >0.05 |